AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 148 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,159,888 | -42.6% | 1,435,553 | -0.2% | 0.00% | -50.0% |
| Q2 2023 | $15,953,523 | -20.2% | 1,438,550 | +10.5% | 0.00% | -33.3% |
| Q1 2023 | $19,986,211 | +80149.8% | 1,302,033 | +16.0% | 0.00% | 0.0% |
| Q4 2022 | $24,905 | -99.8% | 1,122,378 | +19.4% | 0.00% | +50.0% |
| Q3 2022 | $15,344,000 | +24.4% | 939,624 | +10.7% | 0.00% | 0.0% |
| Q2 2022 | $12,331,000 | -9.4% | 848,701 | +15.1% | 0.00% | 0.0% |
| Q1 2022 | $13,614,000 | -19.8% | 737,096 | +3.2% | 0.00% | 0.0% |
| Q4 2021 | $16,977,000 | -6.8% | 714,241 | -3.4% | 0.00% | 0.0% |
| Q3 2021 | $18,208,000 | +78.6% | 739,266 | +79.1% | 0.00% | +100.0% |
| Q2 2021 | $10,197,000 | +15.3% | 412,677 | +1.7% | 0.00% | 0.0% |
| Q1 2021 | $8,847,000 | +30.5% | 405,674 | +52.7% | 0.00% | 0.0% |
| Q4 2020 | $6,777,000 | -11.0% | 265,588 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $7,618,000 | +1493.7% | 270,637 | +1498.5% | 0.00% | – |
| Q2 2020 | $478,000 | – | 16,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |